IFNG and non-small cell lung carcinoma: Given that the majority of NSCLC first-line patients are treated with ICI in combination with chemotherapy, we further explored whether chemotherapy regimens influence IFNγ, B-cell, and DC gene expression changes using the 12 patients from the Tempus cohort 3 treated with platinum-based monotherapy.